The Antibiotic Paradox: Why India’s Overreliance on Powerful Drugs is a Global Wake-Up Call
India’s antibiotic usage is a paradox wrapped in a crisis. A recent Lancet study reveals that the country is leaning too heavily on ‘watch’ antibiotics—powerful drugs meant for specific, hard-to-treat infections—while underusing both first-line ‘access’ antibiotics and last-resort ‘reserve’ drugs. What makes this particularly fascinating is how it reflects a broader global trend: our collective misuse of antibiotics is fueling antimicrobial resistance (AMR), yet millions still lack access to the right medicines.
The Misalignment in India’s Antibiotic Use
India’s antibiotic consumption is skewed. The study estimates that the country should ideally use 14.7 defined daily doses (DID) of antibiotics per 1,000 people daily, with 52.3% coming from ‘access’ antibiotics. In reality, India uses 18.3 DID, with only 27% from the ‘access’ category. This raises a deeper question: Why are doctors prescribing ‘watch’ antibiotics—like ceftriaxone and azithromycin—when simpler, safer options would suffice?
Personally, I think this points to a systemic issue in healthcare practices. Overprescription of ‘watch’ antibiotics isn’t just about individual doctors; it’s a cultural and structural problem. Patients often demand strong antibiotics, believing they’re more effective, while doctors may prescribe them to avoid complications or due to a lack of diagnostic tools. What many people don’t realize is that this overreliance accelerates AMR, making infections harder to treat in the long run.
The Global Double-Edged Sword
India’s situation isn’t unique. The Lancet study found that 72% of countries overuse antibiotics overall, with 99% overprescribing ‘watch’ and ‘reserve’ drugs. Meanwhile, 42% of countries underuse ‘access’ antibiotics, leaving patients without the basic treatments they need. This duality—overuse and underuse—is what makes AMR such a complex challenge.
From my perspective, this highlights a fundamental disconnect in global health policy. High-income countries consume the most ‘watch’ and ‘reserve’ antibiotics, yet 80% of the global need for these drugs lies in lower-income nations. If you take a step back and think about it, this imbalance isn’t just about access; it’s about equity. How do we ensure that antibiotics are distributed fairly while curbing misuse?
The Hidden Implications for India
India’s antibiotic misuse has far-reaching consequences. The National Centre for Disease Control’s 2021-22 survey found that 57% of hospital prescriptions were for ‘watch’ antibiotics, with only 6% based on microbiological evidence. A detail that I find especially interesting is that 55% of prescriptions were for prophylaxis, not treatment. This suggests a preventive mindset, but it also indicates a lack of precision in prescribing practices.
What this really suggests is that India’s healthcare system is caught between two extremes: overprescription of powerful drugs and underuse of diagnostics. This isn’t just a medical issue; it’s a socioeconomic one. Poor access to healthcare in rural areas often leads to self-medication, while urban areas see overuse due to overdiagnosis.
The Way Forward: A Balanced Approach
The solution lies in antimicrobial stewardship—a term that’s often thrown around but rarely implemented effectively. India needs to focus on three key areas:
1. Awareness: Educating both doctors and patients about the risks of overusing ‘watch’ antibiotics.
2. Diagnostics: Investing in rapid diagnostic tools to ensure antibiotics are prescribed only when necessary.
3. Policy: Strengthening regulations to restrict the use of ‘reserve’ antibiotics to truly resistant infections.
One thing that immediately stands out is the need for a global perspective. AMR doesn’t respect borders, and India’s misuse of antibiotics has implications for the world. As Prof. Ramanan Laxminarayan aptly put it, strategies must focus on ensuring access to the right antibiotics at the right time while reducing unnecessary use.
A Provocative Thought to End On
If you take a step back and think about it, antibiotics are a double-edged sword. They’ve saved millions of lives, but their misuse threatens to undo a century of medical progress. India’s antibiotic paradox isn’t just a national issue; it’s a mirror to the world’s failures and excesses.
In my opinion, the real challenge isn’t just about changing prescribing habits—it’s about rethinking our relationship with medicine. Are we using antibiotics as a crutch for systemic failures in healthcare? Or are we treating them as the precious resource they are? The answers to these questions will determine not just India’s health, but the world’s.
